Live from the NIH registry
Studies recruiting near Fairfield right now
Top 25 of 350 recruiting studies, sorted by proximity — each links to its official registry page
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
BASS Medical Group - Lennon — Walnut Creek, California (24.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Kaiser Permanente Center — Vallejo, California (16.1 mi)
· Sponsor: Kartos Therapeutics, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Kaiser Permanente Medical Center-Vacaville — Vacaville, California (7.2 mi)
· Sponsor: NRG Oncology
Healthy Lifestyles for Bipolar Disorder
Time Restricted Eating, Diet, Mediterranean
N/A
Interventional 300 participants sought
University of California — Berkeley, California (29.7 mi)
· Sponsor: University of California, Berkeley
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Walnut Creek, California (24.4 mi)
· Sponsor: AstraZeneca
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Type I Diabetes
Phase 2
Interventional 72 participants sought
Diablo Clinical Research Center — Walnut Creek, California (24.4 mi)
· Sponsor: Op-T LLC
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
One of a Kind Clinical Research Center — Napa, California (13.9 mi)
· Sponsor: Celldex Therapeutics
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Contra Costa Regional Medical Center — Martinez, California (17.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Kaiser Permanente Medical Center-Vacaville — Vacaville, California (7.2 mi)
· Sponsor: NRG Oncology
SELUTION4BTK Trial
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
N/A
Interventional 376 participants sought
St. Helena Hospital — St. Helena, California (29.2 mi)
· Sponsor: M.A. Med Alliance S.A.
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
N/A
Interventional 1,000 participants sought
University of California, Davis — Davis, California (25.4 mi)
· Sponsor: OHSU Knight Cancer Institute
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
John Muir Health Cancer Center ( Site 6028) — Walnut Creek, California (24.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer
Phase 3
Interventional 480 participants sought
Kaiser Permanente Medical Center — Vallejo, California (16.1 mi)
· Sponsor: ArriVent BioPharma, Inc.
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Phase 3
Interventional 1,209 participants sought
GSK Investigational Site — Walnut Creek, California (24.4 mi)
· Sponsor: GlaxoSmithKline
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Kaiser Permanente Medical Center-Vacaville — Vacaville, California (7.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Kaiser Permanente Walnut Creek Medical Center — Walnut Creek, California (24.4 mi)
· Sponsor: Pfizer
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
John Muir Health — Concord, California (19.4 mi)
· Sponsor: Procyrion
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
John Muir Medical Center /ID# 257103 — Concord, California (19.4 mi)
· Sponsor: AbbVie
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Bass Medical Group ( Site 0123) — Walnut Creek, California (24.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Ivonescimab for the Treatment of Thymic Cancer
Thymus Carcinoma
Phase 2
Interventional 25 participants sought
University of California at Davis (UCD) — Davis, California (25.4 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
Nutrition for Precision Health, Powered by the All of Us
Nutrition, Health
N/A
Interventional 8,000 participants sought
University of California, Davis — Davis, California (25.4 mi)
· Sponsor: RTI International
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Sunwise Clinical Research /ID# 248529 — Walnut Creek, California (24.4 mi)
· Sponsor: AbbVie
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1007 — Walnut Creek, California (24.4 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Diablo Clinical Research (DCR) — Walnut Creek, California (24.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Macular Telangiectasia Type 2 (MacTel)
Phase 4
Interventional 234 participants sought
Bay Area Retina Associates — Walnut Creek, California (24.4 mi)
· Sponsor: Neurotech Pharmaceuticals